Two Key Guidelines for the Assessment of Skin Irritation: OECD TG 404 and ISO 10993-23:2021In the biocompatibility assessment of c...
From Repeated-Dose Toxicity to Carcinogenicity: Long-Term Safety Assessment Using OECD Test Guidelines 407, 408, 452, and 453Under...
OECD Guidelines for Acute Inhalation Toxicity: The Right Testing Strategy Using TG 403, TG 433, and TG 436The respiratory tract is...
Acute Dermal Toxicity Tests Using OECD TG 402: Reliable Data on Skin Contact, an Ethical ApproachWhen assessing the potential ri...
A New-Generation Approach to Acute Toxicity: Ethical and Scientific Solutions Based on OECD Guidelines 420, 423, and 425Advances i...
The entire result of a bioequivalence study rests on a single measurement: the concentration of the active ingredient in the blood...
Showing that a medicine is safe and effective is a scientific task; but what determines under which conditions and how this eviden...
Variability and Highly Variable Drugs in Bioequivalence StudiesWhen we look at the result of a bioequivalence study, we often focu...
How Are Bioequivalence Studies Designed?The value of a bioequivalence study lies in its design even before its result. To compare...
What Are Bioavailability and Bioequivalence, and Why Do They Matter?Do two medicines containing the same active ingredient always...